BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24314224)

  • 1. [Interventional therapy for lung cancer patients with superior vena cava syndrome].
    Luo J; Chen B; Jiang S; Zhou SW
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):627-31. PubMed ID: 24314224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
    Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
    AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure?
    Greillier L; Barlési F; Doddoli C; Durieux O; Torre JP; Gimenez C; Kleisbauer JP
    Respiration; 2004; 71(2):178-83. PubMed ID: 15031575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
    Li F; Sun X; Liang S; Jiang S; Mao L
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective stenting study on superior vena cava syndrome caused by lung cancer.
    Wei S; Liu J; Li X; Song Z; Dong M; Zhao H; Zhao Q; Chen G; Chen J
    Thorac Cancer; 2020 Jul; 11(7):1835-1839. PubMed ID: 32438532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior vena cava syndrome revisited.
    Chen YM; Yang S; Perng RP; Tsai CM
    Jpn J Clin Oncol; 1995 Apr; 25(2):32-6. PubMed ID: 7745820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Accelerated hyperfractionation radiation therapy combined with chemotherapy for non-small cell lung cancer complicated with superior vena cava syndrome].
    Ye M; Wang L; Fu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):426-7. PubMed ID: 11810779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell lung cancer with and without superior vena cava syndrome: a multivariate analysis of prognostic factors in 408 cases.
    Würschmidt F; Bünemann H; Heilmann HP
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):77-82. PubMed ID: 7642434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of superior vena cava syndrome in cancer patients with intravascular stent and local thrombolysis].
    Zhang F; Wu P; Huang J
    Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):507-9. PubMed ID: 11235576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential treatment of superior vena cava syndrome caused by of non-small cell carcinoma lung cancer (NSCLC) with vascular stenting and iodine-125 implantation.
    Xiao L; Li Z; Wu L; Sun Z; Yu X
    Technol Cancer Res Treat; 2009 Aug; 8(4):281-7. PubMed ID: 19645521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.
    Lanciego C; Chacón JL; Julián A; Andrade J; López L; Martinez B; Cruz M; García-García L
    AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
    Fagedet D; Thony F; Timsit JF; Rodiere M; Monnin-Bares V; Ferretti GR; Vesin A; Moro-Sibilot D
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):140-9. PubMed ID: 22146975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior vena cava syndrome in small-cell lung cancer.
    Urban T; Lebeau B; Chastang C; Leclerc P; Botto MJ; Sauvaget J
    Arch Intern Med; 1993 Feb; 153(3):384-7. PubMed ID: 8381263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gianturco expandable metallic stents in the treatment of superior vena cava syndrome caused by lung cancer].
    Morita R; Akaogi E; Mitsui K; Kuramoto K; Onizuka M; Ishikawa S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1110-5. PubMed ID: 1324377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of endovascular prostheses as initial treatment for superior vena cava syndrome of malignant cause].
    Talens A; Ferrer S; González-Cruz A; Blanco E; García-Ferrer L; Iranzo V; Camps C
    Med Clin (Barc); 2013 Jan; 140(2):59-65. PubMed ID: 22237043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].
    Pierre MC; Chabbert V; Lozano S; Bigay-Game L; Lévêque N; Desloques L; Otal P; Rousseau H; Didier A; Mazières J
    Rev Mal Respir; 2009 Sep; 26(7):744-50. PubMed ID: 19953016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
    Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI
    Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study in 23 patients of the self-expanding sinus-XL stent for treatment of malignant superior vena cava obstruction caused by non-small cell lung cancer.
    Mokry T; Bellemann N; Sommer CM; Heussel CP; Bozorgmehr F; Gnutzmann D; Kortes NA; Kauczor HU; Radeleff B; Stampfl U
    J Vasc Interv Radiol; 2015 Mar; 26(3):357-65. PubMed ID: 25638748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stenting in malignant obstruction of superior vena cava.
    Shah R; Sabanathan S; Lowe RA; Mearns AJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):335-40. PubMed ID: 8751500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endovascular treatment, with "kissing stents" technique, of superior vena cava syndrome in patient with lung cancer].
    Juszkat R; Zaporowska-Stachowiak I; Stanisławska K; Łuczak J
    Przegl Lek; 2012; 69(7):350-2. PubMed ID: 23276033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.